Company Filing History:
Years Active: 2025
Title: Ines De Silva Serra: Innovator in Cannabidiol Research
Introduction
Ines De Silva Serra is a notable inventor based in Reading, GB. She has made significant contributions to the field of medical research, particularly in the use of cannabidiol (CBD) for treating tuberous sclerosis complex (TSC). Her innovative approach has the potential to change the landscape of treatment for patients suffering from this condition.
Latest Patents
Ines holds a patent for the "Use of cannabidiol in the treatment of tuberous sclerosis complex." This invention relates to the application of CBD in reducing the number and size of marker cells associated with TSC in a zebrafish model. The findings suggest that CBD may have a disease-modifying effect, potentially leading to the reduction or prevention of benign tumors in TSC patients. The patent emphasizes the use of a highly purified extract of cannabis, ensuring that CBD is present at greater than 98% of the total extract, while minimizing the presence of tetrahydrocannabinol (THC) and including cannabidivarin (CBDV) in controlled amounts.
Career Highlights
Ines has worked with prominent companies in the pharmaceutical sector, including Jazz Pharmaceuticals Research UK Limited and GW Research Limited. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Ines has collaborated with notable colleagues such as Benjamin Whalley and William Hind. Their combined expertise has furthered the understanding of CBD's therapeutic potential in treating TSC.
Conclusion
Ines De Silva Serra's work in the field of cannabidiol research represents a significant advancement in the treatment of tuberous sclerosis complex. Her innovative patent and collaborations highlight her commitment to improving patient outcomes through scientific research.